We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

35 hedge funds and large institutions have $16.8M invested in AIM ImmunoTech in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more capital invested

Capital invested by funds: $5.6M → $16.8M (+$11.2M)

117% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 6

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

6% more funds holding

Funds holding: 33 → 35 (+2)

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.41M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.06M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.08M
4
BlackRock
BlackRock
New York
+$1.06M
5
BCM
Bridgeway Capital Management
Texas
+$362K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$168K
2
Wells Fargo
Wells Fargo
California
-$83.1K
3
AWA
Arkadios Wealth Advisors
Georgia
-$35K
4
TRCT
Tower Research Capital (TRC)
New York
-$22K
5
HF
HRT Financial
New York
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$5.69M +$3.41M +15,087 +151%
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.37M +$3.06M +13,556 +237%
BlackRock
3
BlackRock
New York
$2.22M +$1.06M +4,687 +92%
Renaissance Technologies
4
Renaissance Technologies
New York
$1.09M +$1.08M +4,792 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$798K +$264K +1,169 +50%
BCM
6
Bridgeway Capital Management
Texas
$615K +$362K +1,602 +144%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$265K – – –
Verition Fund Management
8
Verition Fund Management
Connecticut
$245K +$108K +480 +80%
Citadel Advisors
9
Citadel Advisors
Florida
$234K +$233K +1,034 New
GCP
10
GSA Capital Partners
United Kingdom
$170K +$131K +578 +338%
Northern Trust
11
Northern Trust
Illinois
$154K +$7.68K +34 +5%
HighTower Advisors
12
HighTower Advisors
Illinois
$143K +$143K +632 New
Cambridge Investment Research Advisors
13
Cambridge Investment Research Advisors
Iowa
$106K +$13.5K +60 +15%
SWM
14
SeaCrest Wealth Management
New York
$99K -$12K -53 -11%
Rockefeller Capital Management
15
Rockefeller Capital Management
New York
$90K +$45.2K +200 +100%
SSA
16
Schonfeld Strategic Advisors
New York
$88K +$86.9K +385 New
VF
17
Virtu Financial
New York
$67K -$168K -744 -72%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$57K -$6.1K -27 -10%
Charles Schwab
19
Charles Schwab
California
$47K – – –
EGM
20
Engineers Gate Manager
New York
$41K +$40.4K +179 New
SFI
21
Susquehanna Fundamental Investments
Pennsylvania
$39K -$7.22K -32 -16%
LPL Financial
22
LPL Financial
California
$37K +$9.03K +40 +32%
Bank of America
23
Bank of America
North Carolina
$34K +$226 +1 +0.7%
CAPTRUST Financial Advisors
24
CAPTRUST Financial Advisors
North Carolina
$32K +$9.03K +40 +40%
CB
25
Community Bank
New York
$30K +$29.8K +132 New
1
2

AIM Hedge Fund Activity: Q1 2021 in Review

35 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2021, worth a combined $16.8M — up 201% from $5.6M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AIM positions and 7 closed out — a net gain of 3 holders — while 13 added to existing stakes and 6 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.41M. The largest seller was Virtu Financial, cutting an estimated $168K.

  • 35 institutional investors held AIM ImmunoTech (AIM) as of Q1 2021, up from 33 in Q4 2020.
  • Funds reported $16.8M of AIM ImmunoTech stock for Q1 2021, up 201% quarter-over-quarter.
  • 10 funds opened new AIM ImmunoTech positions in Q1 2021 and 7 closed out, a net change of +3 holders.
  • The largest AIM ImmunoTech buyer in Q1 2021 was Morgan Stanley, an estimated $3.41M added.
  • The largest AIM ImmunoTech seller in Q1 2021 was Virtu Financial, an estimated $168K sold.

Based on aggregated 13F filings for Q1 2021.